1-20 of 51
Junmin Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ferritin change and predictors of anemia response in ruxolitinib-intolerant myelofibrosis patients treated with gecacitinib

Free
Yi Zhang, Hu Zhou, Zhijian Xiao, Minghui Duan, Sujun Gao, Guangsheng He, Hongmei Jing, Junmin Li, Liangming Ma, Huanling Zhu, Chunkang Chang, Xin Du, Mei Hong, Xin Li, Qingchi Liu, Wei WANG, Na Xu, Haiping Yang, Jie Jin
Journal: Blood
Blood (2025) 146 (Supplement 1): 2029.
https://doi.org/10.1182/blood-2025-2029
Published: 2025
Journal Articles

Prognostic factors for newly diagnosed Acute Myeloid Leukemia with FLT3-TKD - a multicenter retrospective study

Free
Jiaying Lian, Yu Zhu, Zhiling Yan, Qingshu Zeng, Xiaosheng Fang, Suning Chen, Junmin Li, Chunyan Ji, Sili Wang, Fengbo Jin, Fengjiang Zhou, Linhui Hu, Taigang Zhu, Renzhi Pei, Dong Chen, Shuangyue Li, Peipei Ye, Junjie Cao, Ying Lu, East China Leukemia Alliance (Ecla)
Journal: Blood
Blood (2025) 146 (Supplement 1): 5182.
https://doi.org/10.1182/blood-2025-5182
Published: 2025
Journal Articles

Molecular subtype combined with peripheral blast clearance rate to optimize the treatment of newly diagnosed Acute Myeloid Leukemia: Interim analysis of the multicenter, Phase II study (IA+X 2024)

Free
Yunxiang Zhang, Hongming Zhu, Xiangqin Weng, Yongmei Zhu, Jiong Hu, Xiaoxia Hu, Qiusheng Chen, Ligen Liu, Junmin Li, Yang Shen
Journal: Blood
Blood (2025) 146 (Supplement 1): 3436.
https://doi.org/10.1182/blood-2025-3436
Published: 2025
Journal Articles

Adult acute myeloid leukemia with NUP98 rearrangement benefits from targeted therapy and bone marrow transplantation

Free
Hongming Zhu, Yunxiang Zhang, Xia Li, Huafeng Wang, Huarong Zhou, Fengbo Jin, Zhenqi Huang, Yu Zhu, Zheng Ge, Ying Lu, Weimin Chen, Bing Xu, Taigang Zhu, Xiaofei Yang, Shaolei Zang, Chunyan Ji, Qingshu Zeng, Shaoyuan Wang, Suning Chen, Jie Jin, Jiong Hu, Yang Shen, Junmin Li, East China Leukemia Alliance (Ecla)
Journal: Blood
Blood (2025) 146 (Supplement 1): 3391.
https://doi.org/10.1182/blood-2025-3391
Published: 2025
Journal Articles

Characteristics and clinical outcomes of ND-AML patients with bcor/bcorl1 mutations

Free
Shaolei Zang, Chunyan Ji, Xiaosheng Fang, Qingshu Zeng, Suning Chen, Zheng Ge, Zhiling Yan, Junmin Li, Yu Zhu, Shaoyuan Wang, Min Ji, Zhenqi Huang, Xueqing Dou, Hongming Zhu, Bing Xu, Huarong Zhou, Zhiyong Zeng, Hao Chen, Jingtao Wang, Huafeng Wang, Jie Jin, Jingjing Ye, East China Leukemia Alliance China
Journal: Blood
Blood (2025) 146 (Supplement 1): 7005.
https://doi.org/10.1182/blood-2025-7005
Published: 2025
Journal Articles

Olverembatinib (HQP1351) demonstrates efficacy vs. best available therapy (BAT) in patients (pts) with tyrosine kinase inhibitor (TKI)-resistant chronic-Phase chronic myeloid leukemia (CML-CP) in a registrational randomized Phase 2 trial: Up to 4-year follow-up including patients without T315I mutations

Free
Qian Jiang, Zongru Li, Yanli Zhang, Yu Hu, Weiming Li, Yongping Song, Junmin Li, Li Zhou, Bingcheng LIU, Xiaoli Liu, Na Xu, Suning Chen, Zhenfang LIU, Huangling Zhu, Jie Jin, He Huang, Sixuan Qian, Li Meng, Xin Du, Xielan Zhao, Sujun Gao, Yang Liang, Ming Hou, Wei Wang, Zi Chen, Qian Niu, Lichuang Men, Dajun Yang, Yifan Zhai, Xiaojun Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 3788.
https://doi.org/10.1182/blood-2025-3788
Published: 2025
Journal Articles

Ruxolitinib combined with dexamethasone is a promising prophylaxis method for differentiation syndrome in acute promyelocytic leukemia (APL2022)

Free
Hongming Zhu, Yubing Zhao, Xiaojing Lin, Li Chen, Fangyi Dong, Jiong Hu, Junmin Li, Yang Shen
Journal: Blood
Blood (2025) 146 (Supplement 1): 5214.
https://doi.org/10.1182/blood-2025-5214
Published: 2025
Journal Articles

QHRD107 (CDK9 Inhibitor), venetoclax, and azacitidine combination therapy (107VA regimen) in relapsed/refractory Acute Myeloid Leukemia: Data updates and subgroup analysis

Free
Yunxiang Zhang, Min Wu, Wen Wu, Zheng Ge, Ligen Liu, Chunyan Ji, Weiying Gu, Chunling Wang, Yanli Zhang, Wei Yang, Fuling Zhou, Zhengping Yu, Min Ji, Banghe Ding, Shudong Wang, Xiang Zhou, Lijun Wei, Hengwen Song, Yan Zhou, Bomin Yin, Zhichao Shao, Mengdan Sun, Qi Jiang, Junjie Lu, Junmin Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 5205.
https://doi.org/10.1182/blood-2025-5205
Published: 2025
Journal Articles

Long-term treatment continuation of gecacitinib in myelofibrosis patients after ruxolitinib failure

Free
Yi Zhang, Hu Zhou, Qike Zhang, Qingchi Liu, Sujun Gao, Zhijian Xiao, Minghui Duan, Liangming Ma, Wei WANG, Huibing Dang, Guangsheng He, Hongmei Jing, Junmin Li, Haiping Yang, Huanling Zhu, Chunkang Chang, Yuqing Chen, Xin Du, Mei Hong, Xin Li, Jishi Wang, Na Xu, Peng Zhao, Shanshan Suo, Jie Jin
Journal: Blood
Blood (2025) 146 (Supplement 1): 5584.
https://doi.org/10.1182/blood-2025-5584
Published: 2025
Journal Articles

Epidemiology, clinical features, and molecular basis of TTMV :: RARA -driven acute promyelocytic leukemia

Available to Purchase
Xiaosu Zhou, Jiaqi Chen, Yan-Lai Tang, Haibo Sun, Qihui Chen, Xue Chen, Yang Zhang, Jiancheng Fang, Panxiang Cao, Xiaoli Ma, Li Chen, Yangyang Xie, Lijun Wen, Li-Bin Huang, Zhong Fan, Jiacheng Lou, Wenning Xu, Nan Zhang, Jing Li, Yu Luo, Yan Dai, Huan Du, Kun Yang, Zhixu He, Xiaoyan Yang, Linya Wang, Bing Liu, Danna Lin, Yajie Zhang, Fang Xu, Min Zhang, Yang Wang, Shu Yan, Hua Nan, Jing Zhang, Li Xu, Xiujuan Ma, Ruijie Tang, Fang Wang, Lili Yuan, Ming Liu, Lei Wang, Qisheng Wu, Lina Zhang, Siyuan Liu, Chengcheng Yan, Jianfeng Zhou, Fanyong Lyu, Ping Wu, Tong Wang, Xian Zhang, Yue Lu, Deyan Liu, Junfang Yang, Min Xiong, Yanli Zhao, Gaowei Fan, Xia Xiao, Futian Ma, Lihua Yang, Xue-Qun Luo, Junmin Li, Shuhong Shen, Huyong Zheng, Suning Chen, Hongwei Chen, Jianhong Zhao, Zhanglin Zhang, Kankan Wang, Peihua Lu, Hongxing Liu
Journal: Blood
Blood (2025) 146 (18): 2229–2243.
https://doi.org/10.1182/blood.2025028674
Published: 2025
Includes: Supplemental data
Journal Articles

1α,25(OH) 2 D 3 Alleviates Exhaustion and Promotes Antitumor Function of Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells in DLBCL

Free
Mengke He, Fan Zhang, Jie Shen, Zeyi Li, Xiaxin Liu, Chenjing Ye, Hua Yan, Jiong Hu, Junmin Li, Zhen Jin, Rufang Xiang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7133.
https://doi.org/10.1182/blood-2024-202007
Published: 2024
Journal Articles

The Endocannabinoid N-Arachidonoyl Dopamine Induces Leukemia Cell Pyroptosis to Overcome the Venetoclax Resistance

Free
Min Wu, Lingyun Tang, Bo Jiao, Ping Liu, Junmin Li, Ruibao Ren
Journal: Blood
Blood (2024) 144 (Supplement 1): 2206.
https://doi.org/10.1182/blood-2024-202040
Published: 2024
Journal Articles

High Remission Rates in Relapsed/Refractory Acute Myeloid Leukemia with QHRD107 (CDK9 Inhibitor), Venetoclax, and Azacitidine Combination Therapy (107VA regimen) : Preliminary Results of a Phase 2a Study

Free
Min Wu, Yunxiang Zhang, Wen Wu, Zheng Ge, Ligen Liu, Chunyan Ji, Weiying Gu, Chunling Wang, Yanli Zhang, Wei Yang, Fuling Zhou, Zhengping Yu, Min Ji, Banghe Ding, Shudong Wang, Lijun Wei, Hengwen Song, Yan Zhou, Bomin Yin, Zhichao Shao, Mengdan Sun, Qi Jiang, Junjie Lu, Junmin Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 2882.
https://doi.org/10.1182/blood-2024-199412
Published: 2024
Journal Articles

Arsenic Trioxide Combined with Mannitol for the Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia Patients：a Retrospective Study

Free
Yubing Zhao, Zhanyun Liu, Yang Shen, Jiong Hu, Junmin Li, Hongming Zhu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6064.
https://doi.org/10.1182/blood-2024-200772
Published: 2024
Journal Articles

Subgroup Analysis from a Phase 2, Single-Arm Trial of the Oral PI3Kδ Inhibitor Linperlisib in Patients with Relapsed or Refractory Follicular Lymphoma

Free
Tingyu Wang, Xiuhua Sun, Lihua Qiu, Hang Su, Junning Cao, Zhiming Li, Yuqin Song, Li Zhang, Dengju Li, Huijing Wu, Wei Zhang, Junmin Li, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng Li, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, IV, Fei Li, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun Li, Shuhua Yi, Hanying Bao, Zusheng Xu, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6145.
https://doi.org/10.1182/blood-2023-177820
Published: 2023
Journal Articles

Olverembatinib (HQP1351) Demonstrates Efficacy Vs. Best Available Therapy (BAT) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant Chronic Myeloid Leukemia Chronic-Phase (CML-CP) in a Registrational Randomized Phase 2 Study

Free
Qian Jiang, Zongru Li, Gongli Zhang, Yu Hu, Weiming Li, Yongping Song, Junmin Li, Li Zhou, Bingcheng Liu, Xiaoli Liu, Na Xu, Suning Chen, Zhenfang Liu, Huanling Zhu, Jie Jin, He Huang, Sixuan Qian, Li Meng, Xin Du, Xielan Zhao, Sujun Gao, Yang Liang, Ming Hou, Wei Wang, Zi Chen, Qian Niu, Lichuang Men, Dajun Yang, Yifan Zhai, Xiaojun Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 869.
https://doi.org/10.1182/blood-2023-187740
Published: 2023
Journal Articles

A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas

Free
Yuqin Song, Zengjun Li, Huijing Wu, Jie Jin, Hui Zhou, Keshu Zhou, Liling Zhang, Zhigang Peng, Zhiye Zhang, Hong Cen, Youchao Jia, Yuerong Shuang, Zhiming Li, Haiyan Yang, Liqun Zou, Zhifeng Li, Zhihui Zhang, Junmin Li, Junning Cao, Lugui Qiu, Shaojie Wu, Tiejun Gong, Xiaohong Xu, Zhen Wang, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 306.
https://doi.org/10.1182/blood-2023-180137
Published: 2023
Journal Articles

Alrizomadlin (APG-115) Alone or Combined with Azacitidine (AZA) in Patients (pts) with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Relapsed or Progressive Higher-Risk Myelodysplastic Syndrome (HR-MDS): Phase 1b Trial Results

Free
Junyuan Qi, Xudong Wei, Qiubai Li, Chukang Chang, Fuling Zhou, Jianying Huang, Yu Zhang, Chongyuan Xu, Xiaowen Tang, Qian Jiang, Junmin Li, Qun Qin, Qun He, Sujun Gao, Liping Liu, Zi Chen, Min Yu, Jing Wang, Lichuang Men, Hengbang Wang, Mohammad Ahmad, Dajun Yang, Yifan Zhai, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5954.
https://doi.org/10.1182/blood-2023-184959
Published: 2023
Journal Articles

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Chronic Myelomonocytic Leukemia (CMML)

Free
Hongyan Tong, Sujun Gao, Wei Yang, Junmin Li, Qingsong Yin, Xingli Zhao, Xiaojing Yan, Sanfang Tu, Fei Li, Haiping Yang, Ronghua Hu, Shaoyuan Wang, Zheng Dong, Yixuan Yang, Zhenjiu Wang, Qiying Lu, Wenzhi Tian, Zhijian Xiao, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1859.
https://doi.org/10.1182/blood-2023-181501
Published: 2023
Journal Articles

PI3Kδ Inhibitor Linperlisib As a ≥ 3-Line Treatment for Relapsed or Refractory Follicular Lymphoma: A Subgroup Analysis of a Phase II, Single-Arm, Open-Label Trial

Free
Hang Su, Tingyu Wang, Xiuhua Sun, Lihua Qiu, Junning Cao, Zhiming Li, Yuqin Song, Li Zhang, Dengju Li, Huijing Wu, Wei Zhang, Junmin Li, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng Li, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, IV, Fei Li, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun Li, Shuhua Yi, Hanying Bao, Zusheng Xu, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1677.
https://doi.org/10.1182/blood-2023-178710
Published: 2023